OPTOMED — Optomed Oyj Cashflow Statement
0.000.00%
Last trade - 00:00
- €71.46m
- €69.20m
- €15.10m
- 53
- 12
- 74
- 40
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | — | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Net Income/Starting Line | -2.88 | -3.18 | -4.25 | -5.47 | -4.44 |
Depreciation | |||||
Non-Cash Items | 0.822 | 0.627 | 0.52 | -0.152 | 0.757 |
Other Non-Cash Items | |||||
Changes in Working Capital | -0.047 | -2.42 | -1.9 | 0.109 | 0.875 |
Change in Accounts Receivable | |||||
Change in Inventories | |||||
Change in Accounts Payable | |||||
Other Operating Cash Flow | |||||
Cash from Operating Activities | 0.161 | -2.8 | -2.94 | -2.37 | -0.616 |
Capital Expenditures | -1.44 | -1.82 | -2.57 | -3.03 | -2.41 |
Purchase of Fixed Assets | |||||
Purchase / Acquisition of Intangibles | |||||
Other Investing Cash Flow Items | 0.001 | 0.001 | — | — | — |
Acquisition of Business | |||||
Sale of Fixed Assets | |||||
Sale/Maturity of Investment | |||||
Sale of Intangible Assets | |||||
Other Investing Cash Flow | |||||
Cash from Investing Activities | -1.43 | -1.82 | -2.57 | -3.03 | -2.41 |
Financing Cash Flow Items | -4.21 | 0 | — | -0.682 | -0.318 |
Other Financing Cash Flow | |||||
Net Issuance / Retirement of Stock | |||||
Net Issuance / Retirement of Debt | |||||
Cash from Financing Activities | 18.1 | -3.7 | 1.64 | 7 | 1.61 |
Foreign Exchange Effects | |||||
Beginning Cash Balance | |||||
Ending Cash Balance | |||||
Net Change in Cash | 16.9 | -8.26 | -3.8 | 1.72 | -1.41 |